RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 59 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.29 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,712,314 | +57.2% | 618,820 | +35.4% | 0.00% | – |
| Q2 2023 | $2,997,428 | +2020.6% | 456,925 | +1833.1% | 0.00% | – |
| Q1 2023 | $141,349 | +149.6% | 23,637 | -2.7% | 0.00% | – |
| Q4 2022 | $56,626 | -29.2% | 24,303 | +2.1% | 0.00% | – |
| Q3 2022 | $80,000 | +31.1% | 23,803 | +3.4% | 0.00% | – |
| Q2 2022 | $61,000 | -93.5% | 23,012 | -92.7% | 0.00% | – |
| Q1 2022 | $932,000 | -65.6% | 317,027 | +0.0% | 0.00% | – |
| Q4 2021 | $2,709,000 | +23.6% | 316,875 | +7.7% | 0.00% | – |
| Q3 2021 | $2,191,000 | -19.0% | 294,281 | +1.5% | 0.00% | – |
| Q2 2021 | $2,704,000 | – | 289,824 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
| Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
| Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
| NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
| Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
| Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
| Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
| Ergoteles LLC | 37,640 | $126,000 | 0.00% |
| MAI Capital Management | 63,210 | $212,000 | 0.00% |
| RBF Capital, LLC | 14,536 | $49,000 | 0.00% |